PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.776
https://www.valueinhealthjournal.com/article/S1098-3015(19)33154-7/fulltext
Title :
PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33154-7&doi=10.1016/j.jval.2019.09.776
First page :
Section Title :
Open access? :
No
Section Order :
10679